AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05094492 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Curodont Repair Fluoride Plus
Description: P11-4 self assembling peptide combined with fluoride
Study NCT05285137 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline placebo
Description: Sterile normal saline for injection
Study NCT05540210 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: measurement of PSP
Description: one or two blood samples
Study NCT04689217 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: intrathecal drug injection
Description: All patients will be put in the sitting position and lean forward. After sterilization, Dural puncture will be performed at L4-L5 interspace or L3-L4 with a 25 gauge Quincke spinal needle.~The patients will be divided equally into 3 groups according to the additive (fentanyl, nalbuphine or placebo), and all patients will receive the local anesthetic dose of 0.5% heavy bupivacaine according to weight and height
Study NCT04689217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intrathecal drug injection
Description: All patients will be put in the sitting position and lean forward. After sterilization, Dural puncture will be performed at L4-L5 interspace or L3-L4 with a 25 gauge Quincke spinal needle.~The patients will be divided equally into 3 groups according to the additive (fentanyl, nalbuphine or placebo), and all patients will receive the local anesthetic dose of 0.5% heavy bupivacaine according to weight and height
Study NCT05352919 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Litifilimab
Description: Administered as specified in the treatment arm.
Study NCT06005272 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Interviewer assisted completion of questionnaire.
Study NCT05352919 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Litifilimab-matching placebo
Description: Administered as specified in the treatment arm.
Study NCT06464068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: All drugs will be administered intravenously. Induction treatment will be administered on a 21-day cycle for four cycles and will consist of:~* etoposide 80-100 mg/m² (administered on days 1-3 of each 21-day cycle);~* investigator's choice of either carboplatin area under the curve 5-6 mg/mL per min or cisplatin 75-80 mg/m² (administered on day 1 of each cycle);~* durvalumab 1500 mg every 3 weeks in combination with chemotherapy (induction phase) followed by maintenance phase with durvalumab 1500 mg every 4 weeks. Patients will continue treatment until disease progression per investigator assessment, unacceptable toxicity, or other discontinuation criteria were met for a maximum of 24 months. Continuation of study treatment after disease progression will be permitted if there is evidence of clinical benefit for a maximum 24 months.
Study NCT05457764 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality headset
Description: The VR headset was a Pico G2, Pico Interactive, San Fransisco, USA, offering a choice from 60 erotic videos each of 10-30 minutes duration. The men were allowed to watch any and as many of these video clips as they wished. The No VR arm, donors used the computer monitor available in the donation rooms.
Study NCT06260085 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Relatives vioce record
Description: In the study, it was emphasized that the messages to be played to the patient should be 3-5 minutes and simple terms should be used in a way that can be understood by individuals with low education level. Written informed consent was obtained from the patient and the patient's relatives before the application. In the message recorded by a patient's relative decided by the patient's family members, the patient's relative said what he/she wanted to say to the patient and recorded it using a voice recorder. The researcher had a preliminary interview with the patient's relative before the voice recording was taken about the use of the voice recorder and the content of the message (Table 1) in order to prevent the messages from negatively affecting the patient. The voice recording created by the patient's relative was played to the patient by the researcher using a music pillow. After the patient listened to the audio recording, it was erased under the witness of the patient's relative.
Study NCT06349031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Administration of Polyethylene Glycol (PEG) 4000 as per treatment allocation to participants
Description: As per treatment allocation, PEG 4000 will be administered to participants at a dose of 1.5 gm/kg/day dissolved in water until resolution of fecal impaction or a maximum till 6 days whichever is earlier. Fecal impaction Resolution is defined as : Passage of clear liquid stool and no palpable abdominal fecolith
Study NCT06349031 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Administration of Polyethylene Glycol (PEG) 3350 + Electrolyte as per treatment allocation to participants
Description: As per treatment allocation, PEG 3350 + Electrolytes will be administered to participants at a dose of 1.5 gm/kg/day dissolved in water until resolution of fecal impaction or a maximum till 6 days whichever is earlier. Fecal impaction Resolution is defined as : Passage of clear liquid stool and no palpable abdominal fecolith
Study NCT06183424 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Direct Stimulation
Description: 2 mA, 20 min, 5 days
Study NCT06183424 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Transcranial Direct Stimulation
Description: 2 mA, 20 min, 5 days
Study NCT04737967 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Description: Patients will receive will receive Venlafaxine extended release (37.5 mg) tablets once daily(Zimmerman et al., 2016)
Study NCT04737967 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Memantine
Description: Patients will receive memantine (10 mg) once daily (Morel et al., 2016)
Study NCT05743257 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: Each participant completes a questionnaire (online or paper version) about socio-demographic characteristics, health outcomes (general health, respiratory health, and weight status), physical activity and sedentary behaviors, perception of neighborhood characteristics, air quality, and noise exposure.
Study NCT05743257 — intervention group
Intervention type: BEHAVIORAL
Intervention: Food diary supply
Description: Sample of participant was issued with a food supply diary to record details of their household food supply and related trips over 1-mo period. Household food supply included food purchases, food gift/donation, and potential crops. For each food purchase, participants provided details of date, place of purchase and foods purchased (name, quantity and expense incurred). When till receipts were available in grocery stores or supermarkets, participants were asked to collect them in an envelope placed at the end of the food supply diary.
Study NCT05743257 — intervention group
Intervention type: BEHAVIORAL
Intervention: Interviews (semi-structured)
Description: Sample of participants was interviewed about their food provisioning practice and living conditions.
Study NCT04927416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68-Gallium-DOTATATE-PET/CT
Description: 68Ga-DOTATATE is administered one-time via intravenous injection of 5 mCi in a volume of 3-5 ml containing up to 50 mcg \[68Ga\] DOTATATE.
Study NCT05743257 — intervention group
Intervention type: BEHAVIORAL
Intervention: air and noise
Description: Sample of participant were instructed to wear air and noise sensors to record their daily environmental exposure for 7 consecutive days, except for sleeping, bathing and performing activities in the water. Particulate matter concentrations, the temperature, and the relative humidity were measured - the nitrogen dioxide (NO2) and ozone (O3) concentrations were determined with data loggers that integrate reliable electrochemical gas sensors. Noise levels was measured using noise dosimeters. Sensors were accompanied by an activity logbook in which participants were required to daily record time when awake and sleeping, and, if any, time and duration of workout or device removal
Study NCT05094492 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bifluorid 10 fluoride varnish
Description: 5% Sodium Fluoride varnish (equal to 22,600 ppm fluoride)
Study NCT05224310 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PECS block, SAP block
Description: performing either PECS block or SAP block
Study NCT04120038 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Self-Management for Amputee Rehabilitation using Technology [SMART]
Description: Participants will complete a 6-week tablet-based education program for individuals with LLA that will provide them with self-management education.
Study NCT06329713 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Group I: 30 Min Interval Time
Description: 10 ml of a solution containing 0,1% of bupivacaine and 2 mcg/ml fentanyl through the epidural cathether, maintained by programmed intermittant epidural (PIE) boluses of 7,5 ml of the same solution once in every 30 minutes, starting 1 hour after the loading dose. patient controlled epidural analgesia (PCEA) will be programmed so that 8 ml of the same solution with a lock-time of 15 minuts may be administered
Study NCT06329713 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Group II: 60 Min Interval Time
Description: 10 ml of a solution containing 0,1% of bupivacaine and 2 mcg/ml fentanyl through the epidural cathether, maintained by programmed intermittant epidural (PIE) boluses of 15 ml of the same solution once in every hour, starting 1 hour after the loading dose. patient controlled epidural analgesia (PCEA) will be programme
Study NCT05977803 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: MRI with CEST sequence, IVIM and ASL sequence
Description: Three sequences will be added as part of the protocol (for an additional duration of about 10 minutes) :~* The CEST sequence~* The ASL infusion sequence~* The IVIM sequence
Study NCT05021380 — intervention group
Intervention type: OTHER
Intervention: GROUP
Description: Non-invasive diagnosis of dental pain, dental root canal treatment, salivary specimen collection from the first visit to next and the last during 4 weeks of dental care
Study NCT06135454 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Open Wedge High Tibial Osteotomy
Description: For OWHTO,The osteotomy plane, directed from 30 to 35 mm distal to the medial tibial plateau to 10-15 mm distal to the lateral tibial plateau in the coronal plane, was marked by two Kirschner wires with threaded tips. A transverse osteotomy was performed, leaving the lateral cortex intact as a hinge. After the ascending osteotomy and opening. The medial opening gap was filled with two β-TCP wedges and fixed with a TomoFix anatomical plate and locking screws .
Study NCT06135454 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Double Level Osteotomy
Description: The DLO was started from a lateral DFO. A 5-6-cm incision was made proximally at the distal femur from the lateral femoral epicondyle.Two Kirschner wires with threaded tips were inserted to make a length between the wires that was preoperatively planned as the lateral closed osteotomy. Transverse and ascending osteotomies were performed using a Precision Oscillating Tip Saw. The gap was closed and fixed using a TomoFix medial distal femur anatomical plate , which was bent for the lateral distal femur. The subsequent OWHTO was performed as described above.
Study NCT05375240 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol
Description: Propranolol will be given at a dose of 10 mg orally, 3 times per day, for 7 consecutive days after stroke onset.
Study NCT05375240 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Description: Intravenously 2.0g/day for 7 consecutive days.
Study NCT05326204 — intervention group
Intervention type: OTHER
Intervention: Home blood glucose monitoring
Description: Self monitoring of capillary blood glucose
Study NCT05068427 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide
Description: 20mg or 30mg orally twice per week(BIW)
Study NCT05068427 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Envafolimab
Description: 400mg subcutaneous infusions every 4 weeks
Study NCT06145217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
Description: To evaluate the drug-drug interaction between SPRYCEL® 100 mg and Omeprazole under fasted conditions in healthy, adult, human subjects.
Study NCT04410913 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin plus Visual Healing Set and Setting
Description: Psychedelic session (psilocybin 25 mg) with a therapist who will guide and accompany participants before, during, and after the psychedelic session. In addition, participants will have the chance to view nature-themed videos before and after the psychedelic sessions. Four weeks later, a second psychedelic session (psilocybin 25 mg) with either Visual Healing or standard Set and Setting procedures (patient's choice).
Study NCT04410913 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Psilocybin plus Standard Set and Setting
Description: Psychedelic session (psilocybin 25 mg) with a therapist will guide and accompany participants before, during, and after the psychedelic session. Four weeks later, a second psychedelic session (psilocybin 25 mg) with either Visual Healing or standard Set and Setting procedures (patient's choice).
Study NCT01780207 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: PFO Closure
Study NCT06153394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Redesca (enoxaparin sodium for injection)
Description: Redesca is low molecular weight heparin and a biosimilar biologic drug (biosimilar) to Lovenox. Indications have been granted on the basis of similarity between Redesca and the reference biologic drug Lovenox. As such, Redesca (enoxaparin sodium) is indicated for thromboprophylaxis in patients undergoing high risk abdominal and colorectal surgeries. Doses are provided as self-administered subcutaneous injections using a pre-filled syringe with a protective shield.
Study NCT06153394 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fragmin (dalteparin)
Description: Fragmin is a low molecular weight heparin indicated for thromboprophylaxis in patients undergoing high risk abdominal and colorectal surgeries. Doses are provided as self-administered subcutaneous injections using a pre-filled syringe with a protective shield. Our institution uses this drug for standard of care thromboprophylaxis (30 days) in this patient population.
Study NCT05933772 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens A (comfilcon A toric lens)
Description: One month wear
Study NCT05933772 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens B (lehfilcon A toric lens)
Description: One month wear
Study NCT04585386 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual analog scale
Description: to measure the lumbar and radicular pain felt by the patient.
Study NCT04585386 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Visual analog scale
Description: to measure the lumbar and radicular pain felt by the patient.
Study NCT05018468 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ventilation
Description: Patients in group 1 undergo ventilation with an anatomical facial mask and 100% oxygen for three minutes. Patients in group 2 undergo ventilation with a nasal mask and 100% oxygen for three minutes. In both groups, ventilation will be performed with the controlled mode of the anesthesia machine with a volume of 8 cc/kg and a speed of 12-20/min.
Study NCT06356415 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine injection
Description: Group one will receive infraclavicular block using bupivacaine
Study NCT06356415 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine+ Dexamethasone+ Dexmedetomidine
Description: Group two will receive infraclavicular block using dexamethasone and dexmedetomidine added to the bupivacaine
Study NCT04585386 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mac Gill Pain Questionnaire
Description: self-questionnaire that allows a qualitative assessment of chronic pain
Study NCT05258981 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: MRI
Description: Brain MRI
Study NCT04459442 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Umbilical cord clamping at birth.
Description: Umbilical cord clamping after delivery.
Study NCT04585386 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mac Gill Pain Questionnaire
Description: self-questionnaire that allows a qualitative assessment of chronic pain
Study NCT04585386 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Roland and Morris Disability Questionnaire
Description: functional disability scale for assessing low back pain
Study NCT04585386 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Roland and Morris Disability Questionnaire
Description: functional disability scale for assessing low back pain
Study NCT04585386 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quebec questionnaire
Description: To access the patient's perception of incapacity
Study NCT04585386 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quebec questionnaire
Description: To access the patient's perception of incapacity
Study NCT04750148 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 6-minute walking test
Description: The subject walks as far as possible for 6 minutes along a 30m long corridor.
Study NCT04750148 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 2-minute walking test
Description: The subject walks as far as possible for 2 minutes along a 30m long corridor.
Study NCT04750148 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 10-meter walk test
Description: The natural and fast walking speeds of the subject are measured over 10m. This speed is measured by the examiner as well as by the subject (self-tested version).
Study NCT04750148 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: One leg stance test
Description: The time held in unipodal equilibrium is measured by the examiner.
Study NCT05529303 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Such as art therapy, play therapy, breathing techniques
Description: The Cognitive Behavioral Therapy (CBT) model suggests that the individual's dysfunctional thoughts about self, the world, and/or others are based on irrational or illogical assumptions. An individual's self and his/her view of the world are central to the determination of his/her feelings and behaviors and thus can be changed through changing the individual's thoughts, feelings, and behaviors. CBT techniques are in line with the use of expressive art techniques. The common goal in both CBT and expressive arts is to achieve behavior change in the individual. An intervention program has been prepared by the researcher in line with this literature information.
Study NCT06304376 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Alveolar ridge grafting
Description: Alveolar ridge grafting was carried out using anterior iliac crest bone graft. Khoury shell technique was the method of ridge reconstruction via a cortical bone shell was fixed away from alveolar ridge using two micro-screws and the gap created was filled by cancellous bone
Study NCT05333536 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: Experimental group exercises
Description: Experimental performs Strengthening exercises of core.10 reps , 3 sets of each.Prone plank(10 sec hold)(18) ,Side plank (8 sec hold),Bridging (8 sec hold)(19),Bird dog (10 reps ,3 sets),Leg drop (10 reps, 3 sets)(15),Dying bug with their regular swimming practice. First 2 weeks simple strengthening exercises.Next 4 weeks stability ball exercises. Dying bug without stability ball. And strengthening exercises of Upper Limb and Lower Limb with theraband ,10 reps each.Upper Limb: Latissimus dorsi,Serratus anterior, Upper trapezius.Lower limb : Flexors of hip, Extensors of hip,Plantar flexors.
Study NCT05333536 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No Intervention: Control group
Description: control only participates in their yearly swimming trainings.
Study NCT06075498 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: transversus abdominis plane block,
Description: 2 different plan blocks; 1. transversus plane block 2. quadratus lumborum plane block
Study NCT05305053 — intervention group
Intervention type: OTHER
Intervention: preoperative MDT discussion
Description: high-risk patients are subjected to an MDT discussion among care providers
Study NCT05891470 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MonaLisa Touch device
Description: sessions with intra-vaginal CO2 laster system
Study NCT05891470 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vaginal dilatators
Description: Home use of vaginal dilatators (at least twice a week for minimum 5 minutes)
Study NCT05442125 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Using DNA methylome to select embryos
Description: DNA methylation level Embryo with methylation level closest to the optimal level (from one couple patients) is the one for embryonic transfer to uterus
Study NCT05442125 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Using morphologic score to select embryos
Description: blastocyst will transferred according to morphologic score or blastocysts will be biopsied on trophectoderm, sequenced with next-generation sequencing (NGS). Euploidy will transferred one by one according to morphologic score.